Skip Navigation


Human Molecular Genetics Advance Access originally published online on February 19, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/suppl_1/R127    most recent
ddh089v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mata, I. F.
Right arrow Articles by Farrer, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mata, I. F.
Right arrow Articles by Farrer, M. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2004, Vol. 13, Review Issue 1 R127-R133
DOI: 10.1093/hmg/ddh089

Parkin genetics: one model for Parkinson's disease

Ignacio F. Mata, Paul J. Lockhart and Matthew J. Farrer*

Laboratories of Neurogenetics, Department of Neuroscience, Mayo Clinic Jacksonville, FL, USA

The genetic epidemiology of late-onset idiopathic Parkinson's disease (PD) and ‘parkin-proven’ parkinsonism (AR-JP) are limited. The clinical phenotype, prognosis and treatments are similar although PD is prevalent while AR-JP is rare. Molecular genetic and functional analysis suggests the E3 ubiquitin protein ligase activity of parkin, and the ubiquitin-proteosomal pathway, is central to disease pathogenesis. Herein, we compare and contrast PD and AR-JP and discuss the implications of recent data about parkin's genomic organization, regulation and function.

* To whom correspondence should be addressed at: Neurogenetics, Department of Neuroscience, Mayo Clinic Jacksonville, Birdsall Bldg, Rm 206, Jacksonville, FL 32224, USA. Tel: +1 9049530158; Fax: +1 9049537370; Email: farrer.matthew{at}mayo.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
I. H. Henn, L. Bouman, J. S. Schlehe, A. Schlierf, J. E. Schramm, E. Wegener, K. Nakaso, C. Culmsee, B. Berninger, D. Krappmann, et al.
Parkin Mediates Neuroprotection through Activation of I{kappa}B Kinase/Nuclear Factor-{kappa}B Signaling
J. Neurosci., February 21, 2007; 27(8): 1868 - 1878.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Wang, H. S. Ko, B. Thomas, F. Tsang, K. C.M. Chew, S.-P. Tay, M. W.L. Ho, T.-M. Lim, T.-W. Soong, O. Pletnikova, et al.
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function
Hum. Mol. Genet., December 15, 2005; 14(24): 3885 - 3897.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
L. Skipper, Y. Li, C. Bonnard, R. Pavanni, Y. Yih, E. Chua, W.-K. Sung, L. Tan, M.-C. Wong, E.-K. Tan, et al.
Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease
Hum. Mol. Genet., December 1, 2005; 14(23): 3549 - 3556.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
W. Springer, T. Hoppe, E. Schmidt, and R. Baumeister
A Caenorhabditis elegans Parkin mutant with altered solubility couples {alpha}-synuclein aggregation to proteotoxic stress
Hum. Mol. Genet., November 15, 2005; 14(22): 3407 - 3423.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. Gandhi and N. W. Wood
Molecular pathogenesis of Parkinson's disease
Hum. Mol. Genet., September 15, 2005; 14(18): 2749 - 2755.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. R. Sriram, X. Li, H. S. Ko, K. K.K. Chung, E. Wong, K. L. Lim, V. L. Dawson, and T. M. Dawson
Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin
Hum. Mol. Genet., September 1, 2005; 14(17): 2571 - 2586.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. L. Lim, K. C. M. Chew, J. M. M. Tan, C. Wang, K. K. K. Chung, Y. Zhang, Y. Tanaka, W. Smith, S. Engelender, C. A. Ross, et al.
Parkin Mediates Nonclassical, Proteasomal-Independent Ubiquitination of Synphilin-1: Implications for Lewy Body Formation
J. Neurosci., February 23, 2005; 25(8): 2002 - 2009.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
R.-M. Wu, R. Bounds, S. Lincoln, M. Hulihan, C.-H. Lin, W.-L. Hwu, J. Chen, K. Gwinn-Hardy, and M. Farrer
Parkin Mutations and Early-Onset Parkinsonism in a Taiwanese Cohort
Arch Neurol, January 1, 2005; 62(1): 82 - 87.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.